Vaccitech Analyst Ratings
Vaccitech Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/25/2023 | 93.45% | Morgan Stanley | $14 → $3.25 | Downgrades | Overweight → Equal-Weight |
| 08/18/2023 | 733.33% | Morgan Stanley | $15 → $14 | Maintains | Overweight |
| 06/13/2023 | 792.86% | HC Wainwright & Co. | → $15 | Reiterates | Buy → Buy |
| 05/16/2023 | 792.86% | Morgan Stanley | $16 → $15 | Maintains | Overweight |
| 03/29/2023 | 792.86% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 03/27/2023 | 792.86% | HC Wainwright & Co. | $20 → $15 | Maintains | Buy |
| 03/21/2023 | 1090.48% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
| 08/15/2022 | 852.38% | Morgan Stanley | $19 → $16 | Maintains | Overweight |
| 08/11/2022 | 1090.48% | HC Wainwright & Co. | $22 → $20 | Maintains | Buy |
| 05/17/2022 | 1030.95% | Morgan Stanley | $20 → $19 | Maintains | Overweight |
| 05/13/2022 | 1209.52% | HC Wainwright & Co. | $23 → $22 | Maintains | Buy |
| 12/15/2021 | 1269.05% | HC Wainwright & Co. | $25 → $23 | Maintains | Buy |
| 05/25/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 05/25/2021 | 1566.67% | Jefferies | → $28 | Initiates Coverage On | → Buy |
| 05/25/2021 | 1209.52% | Morgan Stanley | → $22 | Initiates Coverage On | → Overweight |
| 05/24/2021 | 1388.1% | HC Wainwright & Co. | → $25 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 09/25/2023 | 93.45% | 摩根士丹利 | $14→$3.25 | 评级下调 | 超重→等重 |
| 2023年08月18日 | 733.33% | 摩根士丹利 | $15→$14 | 维护 | 超重 |
| 2023/06/13 | 792.86% | HC Wainwright公司 | →$15 | 重申 | 购买→购买 |
| 2023年05月16日 | 792.86% | 摩根士丹利 | $16→$15 | 维护 | 超重 |
| 03/29/2023 | 792.86% | HC Wainwright公司 | →$15 | 重申 | →购买 |
| 03/27/2023 | 792.86% | HC Wainwright公司 | $20→$15 | 维护 | 买 |
| 03/21/2023 | 1090.48% | HC Wainwright公司 | →$20 | 重申 | →购买 |
| 2022年08月15日 | 852.38% | 摩根士丹利 | $19→$16 | 维护 | 超重 |
| 2022年08月11日 | 1090.48% | HC Wainwright公司 | $22→$20 | 维护 | 买 |
| 2022/05/17 | 1030.95% | 摩根士丹利 | $20→$19 | 维护 | 超重 |
| 2022年05月13日 | 1209.52% | HC Wainwright公司 | $23→$22 | 维护 | 买 |
| 2021年12月15日 | 1269.05% | HC Wainwright公司 | $25→$23 | 维护 | 买 |
| 2021/05/25 | - | 威廉·布莱尔 | 开始承保 | →跑赢大盘 | |
| 2021/05/25 | 1566.67% | 杰富瑞 | →$28 | 开始承保 | →购买 |
| 2021/05/25 | 1209.52% | 摩根士丹利 | →$22 | 开始承保 | →超重 |
| 2021/05/24 | 1388.1% | HC Wainwright公司 | →$25 | 开始承保 | →购买 |
What is the target price for Vaccitech (VACC)?
Vaccitech(VACC)的目标价是多少？
The latest price target for Vaccitech (NASDAQ: VACC) was reported by Morgan Stanley on September 25, 2023. The analyst firm set a price target for $3.25 expecting VACC to rise to within 12 months (a possible 93.45% upside). 7 analyst firms have reported ratings in the last year.
高科(纳斯达克代码：VACC)的最新目标价是由摩根士丹利于2023年9月25日报道的。这家分析公司将目标价定为3.25美元，预计VACC将在12个月内升至(可能上涨93.45%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Vaccitech (VACC)?
Vaccitech(VACC)的最新分析师评级是多少？
The latest analyst rating for Vaccitech (NASDAQ: VACC) was provided by Morgan Stanley, and Vaccitech downgraded their equal-weight rating.
纳斯达克(Sequoia Capital：VACC)最新分析师评级由摩根士丹利提供，华为下调了两家公司的同等权重评级。
When is the next analyst rating going to be posted or updated for Vaccitech (VACC)?
Vaccitech(VACC)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaccitech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaccitech was filed on September 25, 2023 so you should expect the next rating to be made available sometime around September 25, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Vaccitech的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。对Vaccitech的上一次评级是在2023年9月25日提交的，因此您应该预计下一次评级将在2024年9月25日左右提供。
Is the Analyst Rating Vaccitech (VACC) correct?
分析师对Vaccitech的评级正确吗？
While ratings are subjective and will change, the latest Vaccitech (VACC) rating was a downgraded with a price target of $14.00 to $3.25. The current price Vaccitech (VACC) is trading at is $1.68, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Vaccitech(VACC)评级被下调，目标价为14.00美元至3.25美元。Vaccitech(VACC)目前的交易价格为1.68美元，超出了分析师的预测区间。